DuChemBio Co (XKRX:176750) Retained Earnings : ₩2,958 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. DuChemBio Co's retained earnings for the quarter that ended in Dec. 2023 was ₩2,958 Mil.

DuChemBio Co's quarterly retained earnings declined from Dec. 2021 (₩1,494 Mil) to Dec. 2022 (₩-1,005 Mil) but then increased from Dec. 2022 (₩-1,005 Mil) to Dec. 2023 (₩2,958 Mil).

DuChemBio Co's annual retained earnings declined from Dec. 2021 (₩1,494 Mil) to Dec. 2022 (₩-1,005 Mil) but then increased from Dec. 2022 (₩-1,005 Mil) to Dec. 2023 (₩2,958 Mil).

DuChemBio Co Retained Earnings Historical Data

The historical data trend for DuChemBio Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Retained Earnings Chart

DuChemBio Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

-55,992.62

-63,167.80

1,493.79

-1,005.47

2,958.48

DuChemBio Co Semi-Annual Data
	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Retained Earnings	Get a 7-Day Free Trial			-55,992.62	-63,167.80	1,493.79	-1,005.47	2,958.48

DuChemBio Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

DuChemBio Co (XKRX:176750) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

DuChemBio Co (XKRX:176750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Retained Earnings

Traded in Other Exchanges

N/A

Address

Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3

Website

http://www.duchembio.com

DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines